Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate

We are Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate CAS:163521-20-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate
CAS.NO:163521-20-8
Synonyms:Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate
ethyl 5-piperazin-1-yl-1-benzofuran-2-carboxylate
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 429.0±35.0 °C at 760 mmHg
Molecular Formula C15H18N2O3
Molecular Weight 274.315
Flash Point 213.3±25.9 °C
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.581
 
Specification:
Appearance:White to light yellow powder
Assay(HPLC):≥99.0%
Assay(on dried basis):98.0-102.0%
Loss on drying:≤0.5%
Residue on ignition:≤0.2%
Ethyl 5-amino-1-benzofuran-2-carboxylate:≤0.2%
5-(Piperazin-1-yl)benzofuran-2-carboxylic acid:≤0.2%
Any individual impurity:≤0.2%
Total impurities:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Vilozodone(CAS:163521-12-8).

Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate


Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.3-methylthiopropanol Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).3-Piperazinylpropylmethyldimethoxysilane “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.1-benzyl-4-chloropiperidine CAS:67848-71-9 An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug.Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.

Related Products
Product Name
((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate View Details
methyl 3-(2-methoxy-5-methylphenyl)-3-phenylpropanoate View Details
Lithium tetrakis(pentafluorophenyl)borate ethyl etherate View Details
2,3-Diethyl-5-methylpyrazine manufacturer ETHYL THIOBUTYRATE manufacturer 2,2-Diethoxytriethylamine manufacturer N,N’-bis(4-bromophenyl)-N,N’-bis(4-methylphenyl)-[1,1′-Biphenyl]-4,4′-diamine manufacturer 2-Bromo-5-chlorotoluene manufacturer